See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.38▲ 1.48%
← 0A7L page
XStocksXray
Market X-Ray report · 27 October 2026

iRhythm Technologies, Inc. (0A7L)

London Stock Exchange · UK · prices in USD · close of 27 Oct 2026

Key indicators

Last closeUSD 123.97
52-week range97.71 – 191.13
Return, 1 month / 3 months+12.3% / +10.3%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)67
Volatility (1 year)48.7%
Worst drawdown (1 year)-46.5%
Average daily value traded0.01M USD
Dividend yield–

Market X-Ray price-based

35/ 100 · Medium confidence · ahead of 25% of stocks on this exchange
Trend34
Momentum60
Stability (higher is calmer)26
Liquidity11
Income–

Five-year price chart navy: price · brown: 200-day average

96.901221471721962025-122026-022026-052026-082026-10

About the company

iRhythm Technologies develops wearable heart-rhythm monitoring products and the data services that go with them. Its main offering is a small adhesive patch worn on the chest that records the heart's electrical activity over an extended period while people go about their normal lives. Doctors and health systems use the recordings to look for irregular heartbeats and other rhythm problems. The company is based in the United States and provides both the devices and the analysis of the heart data they collect.

On this site iRhythm Technologies, Inc. appears as a stock on the London Stock Exchange (UK), code 0A7L, with prices in US dollars (USD). Dividend data for this stock is not available yet. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

iRhythm Technologies, Inc. (0A7L) trades on the London Stock Exchange in UK. It last closed at USD 123.97 on 27 October 2026.

Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 2,859 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
iRhythm Technologies, Inc. (0A7L)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend34 · WeakBelow its long-term averages and far from its highs.
Above 200-day average0.8%
From 52-week high-35.1%
Momentum60 · FairTypical recent returns for this exchange.
3-month return10.3%
6-month return-2.6%
12-month return, skipping the last month–
Stability (higher is calmer)26 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)48.7%
Worst drawdown, 1 year (smaller is calmer)-46.5%
Liquidity11 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.01M USD
Zero-volume days5.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+8.5%
1 month+12.3%
3 months+10.3%
6 months−2.6%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average114.95 / 123.01
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.19

Technical summary

DailyStrongly bullish11 bullish · 1 neutral · 3 bearish
WeeklyBullish4 bullish · 1 neutral · 2 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026